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Enterococcus faecalis, a ubiquitous member of mammalian gastrointestinal flora, is a leading cause of nosocomial infections
and a growing public health concern. The enterococci responsible for these infections are often resistant to multiple antibiotics
and have become notorious for their ability to acquire and disseminate antibiotic resistances. In the current study, we
examined genetic relationships among 106 strains of E. faecalis isolated over the past 100 years, including strains identified for
their diversity and used historically for serotyping, strains that have been adapted for laboratory use, and isolates from
previously described E. faecalis infection outbreaks. This collection also includes isolates first characterized as having novel
plasmids, virulence traits, antibiotic resistances, and pathogenicity island (PAI) components. We evaluated variation in factors
contributing to pathogenicity, including toxin production, antibiotic resistance, polymorphism in the capsule (cps) operon,
pathogenicity island (PAI) gene content, and other accessory factors. This information was correlated with multi-locus
sequence typing (MLST) data, which was used to define genetic lineages. Our findings show that virulence and antibiotic
resistance traits can be found within many diverse lineages of E. faecalis. However, lineages have emerged that have caused
infection outbreaks globally, in which several new antibiotic resistances have entered the species, and in which virulence traits
have converged. Comparing genomic hybridization profiles, using a microarray, of strains identified by MLST as spanning the
diversity of the species, allowed us to identify the core E. faecalis genome as consisting of an estimated 2057 unique genes.
Citation: McBride SM, Fischetti VA, LeBlanc DJ, Moellering RC Jr, Gilmore MS, et al (2007) Genetic Diversity among Enterococcus faecalis. PLoS
ONE 2(7): e582. doi:10.1371/journal.pone.0000582
INTRODUCTION
Enterococcal species are core constituents of the intestinal flora of
many animal species ranging from humans to flies [1]. Enterococci
have gained notoriety over the past few decades as frequent causes
of multiple antibiotic resistant, hospital-acquired bloodstream,
urinary tract and surgical wound infections; and because of their
capacity to transfer antibiotic resistances to other microbes [2–5].
Although more than a dozen different enterococcal species have
been associated with human disease, the majority of human
enterococcal infections are due to the species Enterococcus faecalis
[4–8].
The ability of E. faecalis isolates to cause serious infections has
been linked to the intrinsic ruggedness of the bacterium, which
allows the organism to persist in the hospital environment and
survive many host defenses, compounded by the acquisition of
a variety of variable virulence traits by horizontal transfer from
other organisms [9–12]. Examples of variable traits that are known
or suspected of enhancing the virulence of the organism, include
the cytolysin toxin, a gelatinase, enterococcal surface protein Esp,
aggregation substance, a hyaluronidase, and a bile salt hydrolase
[4,7,10,13–16]. Enterococci employ mechanisms, such as phero-
mone-induced plasmid exchange, and contact dependent plasmid
and transposon exchange, to disseminate these traits [4].
Treatment of E. faecalis infections is often confounded by
antibiotic resistance. Beyond the comparatively high level of
resistance that is intrinsic to the species [17], acquired genes confer
resistance to chloramphenicol, clindamycin, erythromycin, tetra-
cycline, high-level aminoglycosides, beta-lactamase, and vanco-
mycin [7]. E. faecalis strain V583 represented the first vancomycin-
resistant enterococcal isolate in the U.S. [18]. Its genome sequence
consisted of more than 25% mobile or foreign DNA elements [19].
In 2002 a transposon well documented in enterococci, was
discovered in a vancomycin-resistant clinical isolate of Staphylococ-
cus aureus [12,20], strongly implicating E. faecalis in the dissemina-
tion of resistances to other species of clinical importance.
Recently, multi-locus sequence typing (MLST) schemes have
been developed to facilitate analysis of a number of bacterial
species [21], including E. faecalis [22–24]. The development of
a facile means for characterizing the genetic background of
a strain makes possible the study of the flow of mobile elements
within the species. Previous studies using MLST to differentiate
isolates of E. faecalis at a subspecies level centered on identifying
virulent clusters and outbreak isolates, as well as plotting the
emergence of antibiotic resistance elements in the population
[22–24]. In this study, we utilize MLST to define the diversity
of the E. faecalis species and to determine the core genome
content.
A collection of 21 E. faecalis strains were previously assembled by
Maekawa and coworkers [25] from approximately 1,000 isolates
and from pre-existing collections, to represent the diversity of the
E. faecalis species as judged by serotyping. Since the genetic basis
for serological identity was unknown, it was of interest to
determine the extent to which serologic diversity reflected genetic
diversity, and to determine the genetic relationships among these
strains. The diversity of this collection was expanded by examining
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interest (i.e. by the discovery of novel traits), commensal strains,
animal isolates, and strains collected from the pre-antibiotic era.
To determine the extent to which traits associated with virulence
and antibiotic resistance had penetrated into the species, these
strains were examined for elements of the E faecalis pathogenicity
island [10], antibiotic resistance, capsule locus polymorphism, and
other traits associated with E. faecalis strains of increased
pathogenic potential. To determine the approximate size and
composition of the core E. faecalis genome, and to comprehensively
assess the penetrance of variable traits identified within the
genome of vancomycin resistant strain V583 into the rest of the
species lineages, strains representing the deepest nodes spanning
the unrooted cladogram derived from MLST data, were
compared by microarray.
MATERIALS AND METHODS
Bacterial strains and culture methods
E. faecalis strains used in this study are listed in Table 1. These
isolates were selected for analysis based on the following criteria:
prior use in E. faecalis diversity studies (i.e., development of
serotyping methods for strain identification), diverse dates of
isolation, association with disease, occurrence in healthy flora,
adoption for use in the laboratory, and historic significance–i.e.,
isolates from the pre-antibiotic era, association with the discovery
of novel virulence determinants, or other notable factors. The
isolation date listed for each strain is based on specific isolation
source data when available, or the earliest known publication in
which a strain is mentioned.
E. faecalis strains were routinely grown on Difco brain heart
infusion (BHI) agar (1.5% w/v, Difco), or in BHI without aeration,
at 37 uC. Genomic DNA was isolated as described [26], and PCR
was performed using standard protocols [27]. All strains used in
this study were verified as being of the species faecalis by PCR,
using the species-specific ddl-1 and ddl-2 primers [28].
MLST analysis
Sequencing of alleles for MLST was performed by the DNA
Sequencing Center for Vision Research (DSCVR) at Massachu-
setts Ear and Eye Infirmary, using an Applied Biosystems BigDye
Terminator V3.1 Cycle Sequencing Kit. Sequencing reactions
were resolved using an ABI Prism 3100 genetic analyzer. A
standard set of E. faecalis MLST primers were used for
amplification and sequencing as described (http://efaecalis.mlst.
net; [21]) and are listed in Table S1. The seven genes evaluated for
MLST of E. faecalis are aroE, gdh, gki, gyd, pstS, xpt, and yqiL. For
each isolate, each gene was amplified a minimum of two times and
sequenced with the specific forward or reverse primer a minimum
of three times. Sequence types of isolates are defined by the allelic
profile at these seven loci, with each unique combination of alleles
assigned a distinct sequence type number. Once an allelic profile
for each isolate was established, dendrograms were created by an
unweighted pair-group method with arithmetic averages, using the
‘View Tree’ link after Batch Query analysis, as previously
described [24]. Isolates with the same allelic profile, and therefore
the same sequence type, are regarded as members of a single clone
or lineage. Clonal complexes were defined as groups of isolates
that differed in no more than two of the seven loci analyzed and
consisted of single and double-locus variants of a founder isolate
determined using eBURST v3 (data not shown; http://www.mlst.
net, [24]).
Dot blot hybridization
Total DNA from enterococcal strains was isolated from overnight
cultures grown in BHI, and 500 ng was spotted onto Hybond-N
+
nylon membranes (Amersham). DNA was fixed by UV cross-
linking with 70,000 mJ/cm
2. Membranes were washed in 26SSC
buffer [27] and blotted dry. Hybridization was carried out using
the DIG-High Prime DNA Labeling and Detection Starter Kit I
(Roche Diagnostics), per manufacturer’s instructions. PCR
products used for probes included amplified internal fragments
of a putative bile acid hydrolase, cbh; capsule locus cpsF; cytolysin
locus cylB; biofilm-related protein encoding esp; gelatinase, gelE;
putative stress regulator, gls-24-like (EF0117); putative glycosyl
hydrolase (EF0077); putative nuclease (EF0031); S. pneumoniae psaA
Mn transporter homolog (EF0095); bifunctional aminoglycoside
inactivating gene aac69-aph20; and the chloramphenicol acetyl-
transferase gene, cat. Each was amplified using primers listed Table
S1. To sample genomes for the presence of portions of the E.
faecalis pathogenicity island (PAI), genes from across the pathoge-
nicity island were selected as shown in Fig S1; sampled regions of
the PAI did not include the 59 most region that contained high
homology to plasmid pAM373, due to the extrachromosomal and
highly variable nature of this DNA in isolates. Genes blaZ and ermB
were detected by PCR using primer pairs ermB-1/ermB-2 and
blaZ-1/blaZ-2, respectively. b-lactamase activity was confirmed
by colorimetric assay. Due to the large diversity of tetracycline
resistance determinants, genotyping for tetracycline resistance was
performed only by PCR for the most common resistance
determinants, tetL, and tetM [29].
Cytolysin transmissibility
The cytolysin operon has been shown to occur on highly
transmissible plasmids, such as pAD1 [30], and within the
chromosome [31], where it has been identified to be encoded
within a pathogenicity island [10]. Portions of the pathogenicity
island, including the cytolysin, transfer at a very low rate [10,32].
To obtain evidence as to whether the cytolysin operon occurred on
a highly transmissible plasmid in strains found to be positive for
this trait, candidate donor strains, and a recipient strain, E. faecalis
FA2-2 (which possesses chromosomal markers for rifampicin and
fusidic acid resistance [33]), were independently grown overnight
at 37uC in BHI. Cultures were then diluted 1:10, combined in
equal proportions, and 50 ul spotted onto non-selective BHI agar
plates and incubated overnight. The resulting mixed colony was
then streaked onto BHI agar containing 5% horse blood 50 mg/ml
rifampicin and 25 mg/ml fusidic acid, to select for isolated
recipient colonies. Streptomycin and spectinomycin (both at
500 mg/ml, using resistant strain JH2SS as the recipient) were
substituted for selection of transconjugants of strain YI6-1 due to
inherent rifampicin and fusidic acid resistance. Hemolytic colonies
were checked for the presence of the unselected resistance,
rifampicin, to verify their status as transconjugants. Conjugation
tests were performed in duplicate.
Capsule Locus Polymorphism
Maekawa serotyping strains T1, T5, and T2 were previously
shown to harbor prototype capsule locus polymorphisms [34]. The
cps locus of Maekawa strain T1 consists of cpsA, and B, followed by
the non-capsule related hcp1 gene [34]. The cps locus of Maekawa
strain T2 consists of cpsA, B, C, D, E, F, G, H, I, J, K, followed by
hcp1. The cps locus of Maekawa strain T5 consists of cpsA, B, C, D,
E, G, H, I, J, K, followed by hcp1, with cpsF conspicuously absent
[34].
Diversity of E. faecalis
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..................................................................................................................................................
Strain Isolation date Source MLST Synonyms and Description References
T1 #1950 unknown 21 SS498; CDC reference strain; from Y. Ike 25, 40, 116, 117
T2 #1992 urine 11 Sapporo-603; Sapporo, Japan; from Y. Ike 25, 40, 116, 117
T3 #1992 urine 67 Sapporo-109; Sapporo, Japan; from Y. Ike 25, 40, 116, 117
T4 #1992 urine 62 Otaru-104; Otaru, Japan; from Y. Ike 25, 40, 116, 117
T5 #1992 urine 68 Kobe-16148; Kobe, Japan; from Y. Ike 25, 40, 116, 117
T6 #1992 urine 63 Tokyo-74; Tokyo, Japan; from Y. Ike 25, 40, 116, 117
T7 #1992 urine 64 Nagasaki-213; Nagasaki, Japan; from Y. Ike 25, 40, 116, 117
T8 #1992 urine 8 Nagasaki-742; Nagasaki, Japan; from Y. Ike 25, 40, 116, 117
T9 #1992 urine 69 Tokyo-10; Tokyo, Japan; from Y. Ike 25, 40, 116, 117
T10 #1992 urine 70 Osaka-34; Osaka, Japan; from Y. Ike 25, 40, 116, 117
T11 #1992 urine 65 Sapporo-027; Sapporo, Japan; from Y. Ike 25, 40, 116, 117
T12 #1992 urine 36 Okinawa-C1; Okinawa, Japan; from Y. Ike 25, 40, 116, 117
T13 #1992 urine 21 Sapporo-6144; Sapporo, Japan; from Y. Ike 25, 40, 116, 117
T14 #1992 urine 9 Tokyo-91; Tokyo, Japan; from Y. Ike 25, 40, 116, 117
T15 1973 wound 40 1824-73; U.S.; from Y. Ike 25, 40, 116, 117
T16 #1951 infant/fecal 19 NCTC8729, s161 type 3; isolated from infant in U.K.; from
Y. Ike
25, 40, 76, 116, 117
T17 #1951 infant/fecal 66 NCTC8734, B8 type 8; isolated from infant in U.K.; from
Y. Ike
25, 40, 76, 116, 117
T18 #1951 infant/fecal 71 NCTC 8730, GB122 type 4; isolated from infant in U.K.;
from Y. Ike
25, 40, 76, 116, 117
T19 #1951 infant/fecal 91 NCTC 8744, D36 type 19; isolated from infant in U.K.;
from Y. Ike
25, 40, 76, 116, 117
T20 #1951 infant/fecal 22 NCTC 8745, N161 type 20; isolated from infant in U.K.;
from Y. Ike
25, 40, 76, 116, 117
T21 #1951 infant/fecal 30 NCTC 8731, N83 type 5; isolated from infant in U.K.;
from Y. Ike
25, 40, 76, 116, 117
F1 early 1900s milk 72 ATCC 376, L36[4]; isolated by S. Orla-Jensen
SS-7 1918 cheese 72 Lancefield C1; from R. Facklam 115
ATCC 4200 3/23/1926 blood 105 R.F.1; rheumatic fever isolate 119, 120
SS-6 1930s unknown 21 Lancefield D76; from R. Facklam
X98 1934 infant/fecal 19 Lancefield H69D6, ATCC 27276 39, 121, 138
ATCC 6055 #1937 milk 113 In1, NCTC5957
D173 7/16/1939 blood 112 18085 (R. Lancefield via V. Fischetti)
ATCC 19433 #1942 ref strain 25 NCTC775, DSM20478, JCM8726, NCDO581, Tissier strain;
control strain for Group D
128, 130
ATCC 10100 #1948 ref strain 114 P-60, NCIB7432, NCIB8644; originally from R. Williams as L.
mesenteroides. Used in assay of riboflavin.
134
RMC1 2/18/1954 clinical 90 54640; from the collection of Roger M. Cole of the NIAID via
D. LeBlanc
RMC5 12/14/1954 clinical 53 546518; from the collection of Roger M. Cole of the NIAID via
D. LeBlanc
B653 4/25/1956 blood/endo 111 10D; blood culture of endocarditis patient (R. Lancefield via V.
Fischetti)
E1 1960s endocarditis 40 MGH Boston, MA; U.S.; from R. Moellering 142, 143
RM3817 1960s blood 40 3817; MGH Boston, MA, U.S.; from R. Moellering 98
RM4679 1960s blood 9 4679; MGH Boston, MA, U.S.; from R. Moellering 98
E1Sol 1960s fecal 93 stool surveillance sample from antibiotic-naive population,
Solomon Islands
144
Ned10 1961 horse 9 D5278/61; Netherlands; from R. Willems
ATCC 27275 #1962 unknown 40 X52 (from P.H. Koppen) 138
RMC65 11/21/1963 unknown 110 63635; from the collection of Roger M. Cole of the NIAID
via D. LeBlanc
39-5 #1964 oral 94 oral isolate from periodontitis (from Rosan&Williams);
contains at least 6 known plasmids; from D. Clewell
75, 139, 145
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FA2-2 #1973 clinical 8 U.K.; Rif/Fus resistant mutant derived from plasmid-free
strain JH2 (Jacob and Hobbs); common laboratory strain
33, 136
JH1 #1974 clinical 40 isolated in U.K.; Kan/Strep/Erm/Tet resistant isolate
containing multiple plasmids; from D. Clewell; common
laboratory strain
33, 137, 141
DS5 #1974 unknown 55 FDA strain PCI1326, ATCC 14508, NCDO2131; Erm/Tet
resistant isolate containing plasmids a, b,a n dc; from
D. Clewell
11, 140
ATCC 29200 #1974 urogenital 21 8413; Quebec, Canada; bacteriophage host 135
OG1RF #1975 oral 1 ATCC 47077; plasmid-free, Rif/Fus resistant mutant of
OG1; common laboratory strain
42, 43
ATCC 27959 #1975 cow 40 NADC A-12; bovine mastitis isolate, Iowa, U.S. 129
5952 #1976 clinical 30 Ann Arbor, MI, U.S.; contains plasmids pOB1? from
D. Clewell
72, 75
DS16 #1978 clinical 40 Ann Arbor, MI, U.S.; contains plasmids pAD1? from
D. Clewell; Tet/Erm/Strep/Kan resistant
9, 74, 136, 146
RC73 #1979 clinical 40 Ann Arbor, MI, U.S.; contains 5 known plasmids; Tet
resistant; from D. Clewell
75
ATCC 35038 1980s chicken 59 NCTC 11428, F87/268, PB21; intestine of young chicken 147, 148
HH22 #1982 urine 6 Houston, TX, U.S.; Erm/Tet/Amp/Gent resistant isolate; first
identified b-lactamase producing E. faecalis; from B. Murray
22, 24, 41, 149
A-2-1 early 1980s infant/sepsis 62 Denver, CO, U.S.; outbreak of neonatal sepsis (1980-1984),
from R. Facklam
127
A-3-1 early 1980s infant/sepsis 40 Denver, CO, U.S.; outbreak of neonatal sepsis (1980-1984),
from R. Facklam
127
B-4-111 early 1980s infant/sepsis 95 Denver, CO, U.S.; outbreak of neonatal sepsis (1980-1984);
from R. Facklam
127
SF19 mid 1980s clinical 6 Michigan, U.S.; Gent resistant isolate; from M. Zervos
MMH594 1985 blood 6 Wisconsin, U.S.; Erm/Gent resistant; first identified and
sequenced pathogenicity island; common laboratory strain
10, 126
SF100 mid 1980s clinical 6 California, U.S. Gent/Strep resistant; from M. Zervos 150
SF105 mid 1980s clinical 9 California, U.S. Gent/Strep resistant; from M. Zervos 150
SF339 1986 clinical 106 Virginia, U.S.; Gent resistant; contains Tn924; from M. Zervos 131, 132
SF350 1986 clinical 64 Winnipeg, Canada; Gent resistant; contains Tn924 and
multiple plasmids; from M. Zervos
131, 132
SF370 1986 clinical 6 Cleveland, OH, U.S.; Gent resistant; contains Tn924; from
M. Zervos
131, 132
WH571 Nov-86 urine 9 Connecticut, U.S.; Gent/Pen/Cm/Erm/Tet/Kan/ Strep
resistant, b-lactamase-producing isolate; from J. Patterson
122-124, 133
CH19 Jul-87 wound 9 Boston, MA; Gent/Pen/Erm/Tet/Strep/Kan resistant,
b-lactamase-producing isolate; from L.B. Rice
118
WH245 #1987 urine 9 West Haven, Connecticut, U.S.; Cm/Strep/Erm/Tet/Pen
resistant, b-lactamase-producing isolate; from J. Patterson
122, 123, 125, 133
WH257 #1987 urine 9 West Haven, Connecticut, U.S.; Gent/Strep/Erm/Tet/Pen
resistant, b-lactamase-producing isolate; from J. Patterson
122, 123, 125, 133
CH570 #1987 blood 6 Canonsburg, PA, U.S.; Gent/Cm/Amp resistant,
b2lactamase-producing isolate; from J. Patterson
122-124, 133
V583 2/12/1987 blood 6 ATCC700802; St. Louis, MO, U.S.; First isolated
Vancomycin-resistant and first sequenced E. faecalis
genome
18, 19
V587 2/26/1987 urine 6 St. Louis, MO, U.S.; Van resistant; (different patient from
V583)
18
CH116 1987-1988 fecal 9 Boston, MA; U.S.; Gent/Kan/Strep/Tet/Erm/Pen resistant,
b2lactamase-producing isolate; from L.B. Rice
118
CH136 1987-1988 urine 9 Boston, MA; U.S.; Gent/Kan/Strep/Tet/Erm/Pen resistant,
b2lactamase-producing isolate; from L.B. Rice
118
CH188 late 80s liver 9 Boston, MA; U.S.; Gent/Kan/Strep/Tet/Erm/Cm?/Pen resistant,
b-lactamase-producing isolate; from L.B. Rice
118
SF1592 late 80s clinical 6 Delaware, U.S.; b-lactamase-producing isolate; from M. Zervos
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Table 1. Cont.
..................................................................................................................................................
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PLoS ONE | www.plosone.org 4 July 2007 | Issue 7 | e582PCR tests were designed to distinguish CPS T1, T2 and T5
type polymorphisms. Primer pair cpsB5-F/hcp1-R (Table S1)
was designed to generate an amplification product of 950 bp
from CPS T1 type strains, as the primers are complementary to
cpsB and hcp1 (EF_2484). Primers cpsEend-F/59cpsG-R were
designed to amplify the region between cpsE and cpsG, to detect
the presence of cpsF, which distinguishes CPS T2 and T5
polymorhpisms. An amplification product of 1098 bp indicated
the presence of cpsF characteristic of the T2 capsule type.
Generation of a product of 199 bp indicated the presence of cpsE
and cpsG, but the absence of cpsF as is characteristic of the CPS
T5 polymorphism. All of the strains examined yielded CPS
locus PCR products consistent with one of the three known
polymorphisms.
Strain Isolation date Source MLST Synonyms and Description References
SF5039 1/1/1991 urine 64 Michigan, U.S.; Van resistant isolate; from M. Zervos
SF6375 10/1/1991 clinical 64 Michigan, U.S.; Van resistant isolate; from M. Zervos
YI6-1 #1992 clinical 28 Japan; Tet resistant, plasmid-free derivative of YI6; first
isolate characterized with chromosomal-encoded cytolysin;
from Y. Ike
31
TR161 10/23/1993 blood 6 Buffalo, NY, U.S. (Sisters Hospital); from T. Russo
TR197 10/30/1993 blood 109 Buffalo, NY, U.S. (Buffalo Gen. Hosp.); from T. Russo
599951 3/6/1994 blood 64 Chicago, IL, U.S.; Van resistant; from M. Hayden
SF21520 mid 1990s blood 6 Valencia, Spain; Van resistant; from M. Zervos 151
SF21521 mid 1990s blood 28 Valencia, Spain; Van resistant; from M. Zervos 151
12030 mid 1990s clinical 64 Cleveland, OH, U.S. 83, 152, 153
12107 mid 1990s clinical 21 Cleveland, OH, U.S. 83, 152, 153
79-3 10/4/1999 blood 64 Chicago, IL, U.S.; Van resistant; from M. Hayden
AR01/DG 8/1/2001 dog* 108 New Zealand; dog wound isolate; First isolated bacitracin
resistant isolate; Van/Erm/Tet resistant; *same as common
Van resistant chicken isolates in N.Z.; from J. Manson
154
SF24396 2001 urine 21 Michigan, U.S.; from M. Zervos
SF24397 2001 urine 2 Michigan, U.S.; from M. Zervos
SF24413 2002 urine 2 Michigan, U.S.; Van resistant isolate; from M. Zervos 155
SF26630 2002 urine 6 Michigan, U.S.; Van resistant isolate; from M. Zervos 155
HIP11704 2002 clinical 4 Michigan, U.S.; Van/Erm strain co-isolated from VRSA
patient (VanA); from L. Weigel
142
Merz89 7/6/2002 blood 40 89; Johns Hopkins Hosp., Maryland, U.S.; esp+ isolate; from
W.G. Merz
156
Merz96 5/3/2002 blood 103 96; Johns Hopkins Hosp., Maryland, U.S.; Van resistant
isolate; from W.G. Merz
156
Merz151 12/6/2002 blood 104 151; Johns Hopkins Hosp., Maryland, U.S.; Van resistant
isolate; from W.G. Merz
156
Merz192 5/5/2002 blood 40 192; Johns Hopkins Hosp., Maryland, U.S.; esp+ isolate; from
W.G. Merz
156
Merz204 7/11/2002 blood 40 204; Johns Hopkins Hosp., Maryland, U.S.; esp+ isolate; from
W.G. Merz
156
SF28073 2003 urine 2 Michigan, U.S.; Van resistant isolate; from M. Zervos 155
Pan7 3/5/2005 commensal 21 Panose 7; fecal sample of healthy volunteer; Boston, MA,
U.S.
Fly1 7/5/2005 drosophila 101 commensal isolate of wild-captured fly; Oklahoma, U.S.;
isolated by C. Cox
Fly 2 2005 drosophila 102 commensal isolate of Oregon R Bloomington fly stock
(immediately upon arrival); isolated by C. Cox
Com1 2/1/2006 commensal 34 fecal sample of healthy volunteer; Boston, MA, U.S.
Com2 2/1/2006 commensal 34 fecal sample of healthy volunteer; Boston, MA, U.S.
Com6 2/1/2006 commensal 21 fecal sample of healthy volunteer; Boston, MA, U.S.
Com7 2/1/2006 commensal 107 fecal sample of healthy volunteer; Boston, MA, U.S.
D1 unknown pig 40 73-30082-2; Denmark; from L.B. Jensen
D3 unknown pig 47 73-30245-2; Denmark; from L.B. Jensen
D6 unknown pig 16 73-30318-4; Denmark; from L.B. Jensen
doi:10.1371/journal.pone.0000582.t001
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Table 1. Cont.
..................................................................................................................................................
Diversity of E. faecalis
PLoS ONE | www.plosone.org 5 July 2007 | Issue 7 | e582Comparative genomic hybridization
Microarray Chip Design A custom Affymetrix GeneChip,
SLARE1 (St. Louis Antibiotic Resistant Enterococcus-1), was
designed to contain a total of 3582 probe sets to: 1) the 3182
predicted ORFs from the chromosome of strain V583 (GenBank
AE016830) [19]; 2) additional pathogenicity island genes of strain
MMH594 known not to be represented in V583 (GenBank
AF454824) [10]; and 3) E. faecalis plasmid and antibiotic resistance
genes or clusters from other E. faecalis strains for which nucleotide
sequences had been reported: vanA operon (GenBank AY697425),
blaZ (GenBank M60253), bcr operon (GenBank AY496968), vanG
operon (GenBank DQ212986), vanE operon (AF430807), tetM
(GenBank X56353), pRE25 plasmid/cat (X92945), pTEF1
(AE016833), pTEF2 (AE016831), and pTEF3 (AE016832).
Microarrays included additionally 111 Affymetrix designed
eukaryotic and prokaryotic negative control probe sets.
Each probe set consisted of 14 perfect-match/single base-
mismatch oligonucleotides per predicted ORF. A total of 42 ORFs
from strain V583 were not represented on the array due to
a combination of synthesis constraints on the potential probes and
cross-hybridization between them and hard prune (repetitive)
elements. A full listing of probe sets including genes represented in
and excluded from the microarray and experimental data are
available in the accompanying supplementary materials deposited
in the ArrayExpress public repository at http://www.ebi.ac.uk/
arrayexpress under accession number E-MEXP-1090. Details of
the algorithm used in construction of custom Affymetrix
GeneChips are available at the manufacturer’s website: www.
affymetrix.com/technology/index.affx.
Bacterial DNA isolation Based on their representation of the
deepest phylogenetic nodes within the MLST dendrogram,
genomic DNA of strains ARO1/DG, Com6, Fly1, HIP11704,
D6, and JH1 was isolated from individual duplicate cultures as
described above. DNA from strains MMH594 and V583 were
included as positive controls. All post-DNA isolation comparative
genomic microarray protocols were performed by Genome
Explorations, Inc., Memphis, TN. Prior to fragmentation and
labeling, the purity and concentration of genomic DNA samples
were determined from A260/280 readings using a dual beam UV
spectrophotometer. Genomic DNA integrity was determined by
capillary electrophoresis using the DNA 12000 Lab-on-a-Chip kit
and the Bioanalyzer 2100 (Agilent Technologies), per
manufacturer’s instructions. The extent of DNA fragmentation
produced by DNase I treatment (see below) was determined by
capillary electrophoresis using the DNA 1000 Lab-on-a-Chip kit
and Bioanalyzer 2100 (Agilent Technologies), per manufacturer’s
instructions.
DNA fragmentation and labeling DNA samples were
adjusted to 0.25N NaOH (Sigma), heated to 65uC and purified
using QIAquick columns (Qiagen) to remove contaminating RNA.
4 mg of DNA was fragmented with DNase I (0.6 U/mg, Promega),
denatured at 95uC, and then labeled with biotinylated dd-UTP
using the Bioarray
TM Terminal Labeling Kit (Enzo). Briefly, each
sample of fragmented DNA was incubated with 20 mlo f5 6
Reaction Buffer, 10 mlo f1 0 6 CoCl2,1 ml of 1006 Biotin-
ddUTP, and 2 mlo f5 0 6Terminal Deoxynucleotide Transferase
for 2 hr at 37uC. Reactions were terminated by addition of EDTA
(pH8.0) to a final concentration of 6 mM.
Oligonucleotide array hybridization and analy-
sis Labeled genomic DNA fragments were adjusted to contain
0.06M MES-Na buffer (Sigma), 2.7 M TMACl (Sigma), 5%
DMSO (Sigma), 0.01% Tween-20 (Sigma), 2.56 Denhardt’s
solution, and 0.1 mg/ml herring sperm DNA (Promega), and
hybridized for 16 hr at 48uC to the custom designed E. faecalis
genome array SLARE1 (Affymetrix). Arrays were washed at 25uC
with 6 6 SSPE (0.9 M NaCl, 60 mM NaH2PO4,6 m M
EDTA)+0.01% Tween-20 followed by a stringent wash at 50uC
with 0.66SSPE+0.01% Tween-20. The arrays were then stained
with phycoerythrein-conjugated streptavidin (Molecular Probes)
and the fluorescence intensities were determined using the GCS
3000 high-resolution confocal laser scanner (Affymetrix). The
scanned images were analyzed using programs resident in
GeneChip Operating System v1.4 (GCOS; Affymetrix). GCOS-
generated signal intensity values and detection calls for probe sets
covering prokaryotic and eukaryotic control sequences, and E.
faecalis sequences, were used to assess hybridization quality and
specificity after standardization of each array. Standardization was
accomplished by global scaling the average of the fluorescent
intensities of all probe sets on an array to a constant target
intensity of 250 for all arrays used. Scale factors produced by
global scaling were similar to normalization factors generated
using 50% trimmed mean signal intensity values.
Comparative genotyping and bioinformatic analyses To
identify absent or divergent sequences in each strain (relative to the
published sequences for the V583 genome, the E. faecalis
pathogenicity island, plasmids pTEF1, pTEF2, pTEF3 and
pRE25, the vanE, vanG and bcr operons, and the vanA, tetM, and
blaZ genes), GCOS-generated detection calls for each probe set
were first converted to numerical values (A=0 [absent], M=0.5
[ambiguous], P=1.0 [present]) and averaged from duplicate
experiments for each strain. Average signal intensity values were
calculated for probe sets with detection values=1.0 in all eight
strains (overall AvgSigPresent=332.86). By comparison, the average
signal intensity value for probe sets with detection values=0 in all
eight strains was 29.85. A final detection call of Present (or non-
divergent) was assigned to each probe set in a strain if two criteria
were met: 1) log2 [strain average signal value/average signal value
for all 8 strains] $21.5, and 2) log2 [strain average signal value/
Overall AvgSigPresent] $23.0. These criteria set a limit on strain
to strain variability and an absolute signal intensity requirement
for a call of Present (or non-divergent). Relative strain divergence
was assessed based on 1) the percentage of non-divergent probe
sets called ‘‘present’’ in each strain and 2) Pearson correlation
coefficients. Dendrograms depicting relative strain divergences
were generated in GeneMaths XT (Applied Maths) based on
a similarity matrix of Pearson correlation coefficients using the
Combined Linkage algorithm. Cluster maps aligned strains
according to similarity dendrogram and probe sets according to
1) the number of strains in which each probe set was called
Present, and then by COG designation, or 2) the genomic order
specified in the GCOS-generated CHP file. Cluster maps were
generated in GeneMaths XT. Gene descriptions and COG
designations were obtained from the National Center for
Biotechnology Information (NCBI).
Microarray values were ambiguous for the two-component
histidine kinase and response regulator HK14 and RR14
(EF_1209 and EF_1210) for strains Fly1 and Aro1/DG, and for
the histidine kinase HK17 (EF_1632) for strains MMH594 and
V583. These loci were confirmed present by PCR using primer
sets detailed in Table S1.
Phenotype Assays
b-lactamase assay Direct assessment of b-lactamase activity
was performed using the colorimetric Nitrocefin disk assay (Remel
Co., U.K.), per manufacturer’s instructions.
Cytolysin assay Blood agar plates were used for the
qualitative detection of hemolytic activity. Plates contained Bacto
brain-heart infusion and 1.5% agar, to which PBS washed horse
Diversity of E. faecalis
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Strains were streaked for isolation on blood agar and assessed after
24 hours for zones of hemolysis surrounding colonies [35].
Bile salt hydrolase (CBH) assay Isolates were grown
overnight at 37uC in brain-heart infusion broth, and 5 ml were
spotted onto plates containing 70 g/l Difco MRS Lactobacilli
medium, 0.37 g/l calcium chloride (Sigma-Aldrich), and 0.5%
taurodeoxycholic acid (Sigma-Aldrich #T0557), hereafter referred
to as CBH agar [36]. E. faecalis strains were grown for 48 hours
and examined for precipitation of deconjugated taurodeoxycholic
acid.
Gelatinase assay Gelatinase expression was detected by the
observance of a halo around isolated colonies streaked on BHI
skim milk agar [37]. Strains for which no halo of clearing around
colonies was observed following 48 h of incubation at 37 uC were
considered phenotypically negative.
Antibiotic resistance assays All strains were tested for
antibiotic resistance using a single-concentration assay, analogous
to that developed for detection of high-level aminoglycoside
resistance [38]. The following antibiotics and concentrations were
used to assess resistance: gentamicin, 500 mg/ml; erythromycin,
50 mg/ml; chloramphenicol, 10 mg/ml; tetracycline, 10 mg/ml;
ampicillin, 4 mg/ml and 8 mg/ml; and vancomycin, 4 mg/ml and
8 mg/ml (Sigma-Aldrich). Assays were performed with fresh cells
(approximately 10
6 CFU) from BHI agar suspended in 100 ml BHI
medium containing antibiotic. Growth was monitored after
24 hours (48 hours for vancomycin resistance), and compared to
known positive and negative controls. Experiments were
performed a minimum of two times with analogous results.
Chloramphenicol acetyltransferase assay Isolates
identified as resistant to chloramphenicol by microdilution assay,
but probe negative for the cat gene by PCR and dot blot, were
assayed specifically for CAT activity using a FAST CATH Green
(deoxy) chloramphenicol acetyltransferase detection kit, and
analyzed by thin-layer chromatography as recommended by the
manufacturer (Molecular Probes, U.S.A.).
RESULTS
Phylogenetic analysis of E. faecalis serotyping
isolates
In 1992, S. Maekawa and her colleagues [25] developed a refined
serotyping test for the rapid identification of the majority of E.
faecalis strains. Rabbit antisera were exhaustively cross adsorbed
against a battery of E. faecalis isolates, including a smaller serotype
diverse set previously created by M.E. Sharpe in 1964 [39]. Upon
examining 832 strains from the U.S., Japan, and the U.K. in their
study, over 78% of all isolates fell into one of 21 proposed
serotypes, with serotypes 1, 2, 4, 7, and 9 representing the majority
of isolates [25,40]. Because of the established diversity of this set of
E. faecalis serotyping strains, it represented an ideal starting point
for determining the genetic diversity of E. faecalis strains. Using
MLST, we assessed the genetic relatedness of the 21 Maekawa
type strains (T1-T21). A dendrogram depicting the relationships
between these strains is shown in Fig. 1. These results indicate that
the 21 serotypes of E. faecalis in fact span a great amount of species
diversity and identify genetically distinct lineages. Only 2 of the 21
strains, strain T1 and T13, were found to be of the same sequence
type.
Test for additional species diversity
The extent to which the Maekawa serotyping strains represented
the diversity of the E. faecalis species, was tested by examining
additionally 85 strains drawn from diverse ecologies and points
in time. This set includes strains isolated from New Zealand to
Boston, and dates ranging from the early 1900s to 2006. The
collection also included clinical specimens, hospital-unrelated
fecal isolates, and strains from non human sources ranging from
Drosophila to swine. MLST analysis was performed on
these additional isolates, lis t e di nT a b l e1 ,a n dt h eg e n e t i c
relationship of these strains to the Maekawa strains is shown in
Figure 2.
Within this diverse origin strain set, some sequence types
(hereafter STs) occurred multiple times. The five most common
STs were ST40 (n=13), ST6 (n=12), ST9 (n=11), ST21 (n=8),
and ST64 (n=7), which include 2 of the 5 serotypes identified as
common by serotyping [40]. Additionally, these five most common
STs had closely related single locus variants (SLVs) and/or double
locus variants (DLVs) in our collection. The largest clonal clusters
(CCs) in this diversity collection, defined here as a ST represented
by three or more isolates, along with any SLVs and DLVs of these
sequence types, include: CC21 (consisting of ST21 and ST70),
CC9 (ST9 and ST106), CC2 (ST6 and ST2), CC8 (ST64, ST8,
ST90, and ST112), and CC40 (ST40 and ST114). In all, the five
Figure 1. Dendrogram created from serological typing strains using
the E. faecalis MLST database efaecalis.mlst.net. Multi-locus sequence
typing (MLST) of E. faecalis isolates was based on sequences of internal
gene fragments for 7 housekeeping genes. Each gene variation (for
each of the seven genes) is assigned a unique allele number. The
combination of the 7 allele numbers (allelic profile) for each strain
defines the multi-locus sequence type, or ST. The relatedness of isolates
based on sequence type is shown as an unrooted cladogram,
determined by (UPGMA) analysis of the allelic profiles. Boxed isolates
represent the most common serotypes found in human populations in
previous studies [25,40].
doi:10.1371/journal.pone.0000582.g001
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examined by MLST in this study.
Interestingly, of the E. faecalis strains that have been used for
most laboratory studies, namely strains V583 (first E. faecalis
genome sequenced) [19], MMH594 (first pathogenicity island
description) [10], HH22 (first b-lactamase positive isolate) [41],
FA2-2 [33], and OG1RF [42,43], only one common sequence
type is represented: ST6 (HH22, V583, and MMH594). We
previously showed extensive sequence conservation within the 129
genes of the pathogenicity island and the 11 genes of the capsule
locus of V583 and MMH594 [10], and others have observed that
these strains and HH22 are closely related in genes that define the
MLST assessment loci [22]. In this study, as in [24], these strains
were identified as ST6. OG1RF was identified as representing the
rarer sequence type ST 1, and FA2-2 is ST8.
When the MLST data of the Maekawa et al. [25] serotyping
strains T1-T21 (Fig. 1) are viewed on the dendrogram in Fig. 2,
these isolates (highlighted in yellow) in fact span the diversity of
sequence types at many grades of relatedness. This was somewhat
surprising given that the molecular basis for interaction of
agglutinating serotype anti-serum with the surface of the each of
the sequence types is unknown, except for type 2 [44].
Of the isolates in our collection from the era preceding the
widespread use of antibiotics (which we defined as having been
acquired #1951), strains are found throughout the dendrogram,
with only one isolate out of fifteen (SS-6) belonging to one of the
most common STs of this study (ST21). No obvious clustering of
older isolates is observed.
Capsule locus polymorphisms and distribution
among isolates
All strains from Table 1 were analyzed for genes associated with
virulence in E. faecalis, or homologs linked to virulence in other
organisms (see Table 2 and Fig. 2). Isolates were first examined at
the capsule locus (cps) to determine which of the known capsule
polymorphisms occurred. The cps capsule locus of E. faecalis was
discovered in part using Maekawa serotyping antiserum (serotype
2/strain T2). The T2 cps operon consists of 11 open reading
frames, designated cpsA through cpsK [34,44,45]. Based on
observed cps operon polymorphisms [34], primers were designed
to assess these polymorphisms within our collection. Maekawa
‘type’ strains T1-T21 were verified as possessing the combinations
of the 11 known genes of the cps operon previously inferred from
restriction fragment length polymorphism and dot blot analysis
(35, 77), and to verify the basis for the 3 previously identified
polymorphisms (35, 77) using primers listed in Table S1. For all of
the Maekawa serotype strains tested, the three known capsule
operon polymorphisms were found: 1) that which includes all 11
genes as in strain T2 (designated CPS type 2); 2) that which
includes all genes except for cpsF as in Maekawa strain T5 (CPS
type 5); or only cpsA and cpsB as found in Maekawa strain T1 (CPS
type 1).
A limited primer set, optimized to detect the differences
between these 3 capsule operon polymorphisms, was then used
to determine which of the three CPS types were present in the
remaining isolates of the collection. All strains tested yielded one of
Figure 2. Dendogram of isolates aligned with capsule type, pathogenicity island segments, and antibiotic resistance traits. MLST-based
dendrogram showing genetic relationship of all E. faecalis isolates in this study. Small yellow highlights indicate a serotyping type strain, while black
boxes designate the five most common serotypes [40]. Arrows designate isolates used for comparative genomic microarray analysis. Abbreviations
are defined as follows: ST=sequence type; CPS=capsule type; PAI=pathogenicity island fragment outlined as letter designations in Fig. S1 (A=nuc1;
B=cylB;C=esp; D=hydrolase homolog similar to xylS;E=psaA homolog; F=gls-24 like); A red letter B indicates strains that readily transfer cytolysin
via mating; Ab
R=antibiotic resistance; T=tetracycline resistance; TM=tetM+;T L=tetL+;E=ermB+;V A=vanA+;V B=vanB+; G=gentamicin resistant;
C=cat+;A=blaZ+; CBH=bile salt hydrolase; GEL=gelatinase; CYL=cytolysin. More detailed strain information is listed in Table 1.
doi:10.1371/journal.pone.0000582.g002
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products. Dot blots were performed on the entire collection, using
as a probe an internal fragment of cpsF, to confirm presence or
absence of the cpsF gene, which is characteristic of CPS2, and to
verify that negative PCR results did not derive from point changes
within primer hybridization sites. The occurrence of CPS 1, 2 and
5 polymorphisms among the strains studied, as identified by this
approach, is shown in Figure 2. Wherever the collection contained
multiple isolates within a sequence type, CPS type was invariant
among those strains. The most common CPS type among the
diversity of lineages was type 1. When strains were examined by
decade of isolation, CPS type 1 remained most common.
Antibiotic resistances and determinants among
isolates
Single-concentration broth assays were performed to test the
resistance of isolates to antibiotics from six different classes:
gentamicin, erythromycin, ampicillin, vancomycin, tetracycline,
and chloramphenicol. For many isolates, some antibiotic re-
sistance information was available. Reanalysis confirmed those
results, with the exception of strain CH19, for which erythromycin
resistance was not detected by phenotype. This strain was,
however, found to harbor the ermB resistance gene. Based on the
broth assay results, 58% of isolates exhibited resistance to
tetracycline, 38% to erythromycin, 33% to high-level gentamicin,
14% to vancomycin, 11% to chloramphenicol, and 9% to
ampicillin. An additional 6 strains exhibited low-level (#4 mg/
mL) ampicillin resistance, but were b-lactamase negative (strains
F1, RMC1, SF5039, SF21520, SF21521 and Merz96). Tetracy-
cline resistance was the only antibiotic resistance trait that
occurred among isolates included in this study known to be of
commensal origin [46]. Of isolates tested, 31% (34/106) were
sensitive to all six antibiotics. All strains isolated prior to 1954 were
susceptible to all of the antibiotics tested. Less than half of CC21
isolates, which includes sequence types 21 and 70, had any
antibiotic resistance, with tetracycline being the sole resistance
found. Strains of CC40, which includes sequence types 40 and
114, also exhibited relatively few antibiotic resistance factors, with
most isolates having only one type of resistance.
Clonal clusters CC9, CC2, and CC8 contained strains that
harbored many resistances, with some isolates carrying determi-
nants for resistance to five antibiotic classes. Vancomycin
resistance, conferred by the vanA or vanB genetic determinants,
was found in 14% of isolates, with most occurring in CC2 and
CC8 (10/15). Ampicillin resistance conferred by b-lactamase was
only found in isolates from CC9 and CC2 of our collection,
specifically in sequence types 9 and 6 (Fig. 2 and Table 3), and was
the rarest among this collection (Table 3). The number of
antibiotic resistances found in each genetic lineage is illustrated in
Fig. 3.
Strains were tested by PCR and dot blot for the antibiotic
resistance genes most commonly conferring these resistances in E.
faecalis. These included tetM and tetL for tetracycline resistance
[47,48], blaZ for b-lactamase-mediated ampicillin resistance [49],
aac69-aph20 for aminoglycosides [50], cat for chloramphenicol [51],
vanA and vanB for glycopeptides [52–54], and ermB for macrolide
resistance [55] (Table 2 and Fig. 2). Comparing antibiotic
resistance phenotype and genotype, we found that all erythromy-
cin resistant strains were positive for ermB (Fig. 4). Further, all
vancomycin resistant isolates contained either vanA or vanB ligases,
and all high-level ampicillin resistant (.4 mg/mL) isolates
Table 2. Bacterial virulence determinants and putative virulence factors examined.
..................................................................................................................................................
Bacterial Determinant Accession no. Putative function Reference Method of detection
PAI
nuc-1 EF0031 nuclease (homolog) 10 PCR, Southern hybridization
cylA,B,&M EF0046-48 cytolysin production 35 PCR, Southern hybridization for cylB
esp EF0056 enterococcal surface protein 10 PCR, Southern hybridization
hydrolase EF0077 glycosyl hydrolase (xylS homolog) 10 PCR, Southern hybridization
psaA EF0095 metal binding protein (homolog) 157 PCR, Southern hybridization
gls24-like EF0117 general stress protein 10, 158 PCR, Southern hybridization
cbh EF0040 bile salt hydrolase 10 PCR, Southern hybridization, CBH assay
Other
cps EF0085-95 capsular polysaccharide 44 PCR, Southern hybridization
gelE D85393 gelatinase 68, 159, 160 PCR, Southern hybridization, Gelatinase assay
fsrB EF1821 accessory gene regulator 68 PCR
Antibiotic resistance
vanA X56895 D-Ala-D-Lac ligase / Vancomycin resistance 52, 54 PCR, microdilution assay
vanB L06138 D-Ala-D-Lac ligase / Vancomycin resistance 53, 54 PCR, microdilution assay
ermB U86375 adenine methylase/ erythromycin resistance 55 PCR, microdilution assay
cat X92945 chloramphenicol acetyl-transferase/
chloramphenicol
51 PCR, Southern hybridization, resistance assay FAST
CAT assay
tetM X92947 ribosomal protection / tetracycline resistance 48 PCR, Southern hybridization, resistance assay
tetL NC_005013 efflux pump / tetracycline resistance 47 PCR, Southern hybridization, resistance assay
aac6’-aph2" M13771 bifunctional enzyme / high-level
aminoglycoside resistance
50 PCR, Southern hybridization, resistance assay
blaZ M60253 b-lactamase / b-lactam resistance 49 PCR, nitrocefin assay, resistance assay
doi:10.1371/journal.pone.0000582.t002
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PLoS ONE | www.plosone.org 9 July 2007 | Issue 7 | e582expressed b-lactamase activity and possessed the gene, blaZ. The
majority of tetracycline resistant isolates (54 of 62) carried tetM,
one isolate was positive for tetL, and 12 of the 54 tetM positive
isolates also carried the tetL gene. The remaining 7 tetracycline-
resistant strains tested negative for either tetM or tetL by PCR, and
may be resistant via one of the rarer tetracycline resistance
mechanisms not examined [29]. Most gentamicin resistant isolates
(32/34) were positive by PCR and dot blot for the aac69-aph20
bifunctional enzyme that confers aminoglycoside resistance [50],
with the exceptions of strain JH1 and YI6-1, which had high-level
gentamicin resistance and were not positive for aac69-aph20. JH1
was previously described as having a 3950-aminoglycoside
phosphotransferase type III resistance gene [56]. The aminoglyco-
side resistance mechanism for YI6-1 was not further explored.
Chloramphenicol resistance was associated with the presence of
the chloramphenicol acetyl-transferase gene, cat, by PCR and dot
blot, for all chloramphenicol resistant strains except RM4679,
WH245, and WH571, which were phenotypically chloramphen-
icol resistant, but were negative for the cat gene by these tests.
Because chloramphenicol acetyl transferase (CAT) is the most
common mechanism for chloramphenicol resistance in enterococ-
ci [57,58], we further evaluated CAT activity in these isolates
using the FAST CAT chloramphenicol acetyltransferase kit. CAT
activity was confirmed for all three strains, suggesting that they
harbor a divergent cat gene [57]. The number of isolates having
the tested antibiotic resistance phenotypes and genotypes listed
above are illustrated in Fig. 2.
Known and suspected virulence traits
A number of auxiliary traits have been identified that participate
in colonization or virulence in E. faecalis, or are similar to those of
known activity in other intestinal pathogens [59,60]. We examined
our collection of isolates for assayable activities associated with
virulence, and corresponding coding sequences: cytolysin, gelati-
Figure 3. Dendrogram and composite virulence determinants among sequence types. MLST-based dendrogram compiling data from isolates of
the 51 identified sequence type lineages. PAI=number pathogenicity island genes present per lineage; Ab
R=number of antibiotic resistance
determinants per lineage. Brackets encompass abundant clonal isolates and their single and double locus variants where applicable.
doi:10.1371/journal.pone.0000582.g003
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PLoS ONE | www.plosone.org 10 July 2007 | Issue 7 | e582nase, and bile salt hydrolase (Fig 2). Cytolysin and gelatinase
production were characterized in E. faecalis over 40 years ago [61–
63], and many studies have linked these variable traits of the
species to enterococcal virulence [64,65]. Bile salt hydrolase is
expressed by some strains of E. faecalis, and also by intestinal
pathogens [66,67]. It is known to contribute to a bacterium’s
ability to survive in the gastrointestinal tract [15]. Analysis of
phenotypes and corresponding genotypes for cytolysin, gelatinase,
and bile salt hydrolase activity, revealed more isolates that were
genotypically positive than phenotypically positive in laboratory
tests (Fig. 4). The greatest difference between genotype and
detectable phenotype was for gelatinase activity (58 gelatinase
positive of 104 gelE
+), then cytolysin (26 cytolysin positive of 36
cylA/B/M
+), followed by bile salt hydrolase (71 hydrolase positive
Table 3. Distribution of putative virulence genes in five most common clonal groups.
..................................................................................................................................................
clonal group CC21 CC9 CC2 CC8 CC40 non-clustering Total from groups
# of isolates 91 21 51 11 44 5 6 1
bla 0 (0/9) 58 (7/12) 20 (3/15) 0 (0/11) 0 (0/14) 0 (0/45) 16 (10/61)
cat 0 (0/9) 50 (6/12) 20 (3/15) 18 (2/11) 7 (1/14) 2 (1/45) 20 (12/61)
vanA/B 0 (0/9) 0 (0/12) 40 (6/15) 36 (4/11) 0 (0/14) 11 (5/45) 16 (10/61)
ermB 0 (0/9) 67 (8/12) 87 (13/15) 64 (7/11) 14 (2/14) 24 (11/45) 49 (30/61)
aac6’-aph2" 0 (0/9) 67 (8/12) 100 (15/15) 27 (3/11) 0 (0/14) 16 (7/45) 43 (26/61)
tetM/L 44 (4/9) 58 (7/12) 40 (6/15) 82 (9/11) 79 (11/14) 40 (18/45) 61 (37/61)
gls-24-like 0 (0/9) 0 (0/12) 67 (10/15) 9 (1/11) 0 (0/14) 18 (8/45) 18 (11/61)
cylB 22 (2/9) 33 (4/12) 47 (7/15) 36 (4/11) 29 (4/14) 31 (14/45) 34 (21/61)
nuc1*0 (0/9) 83 (10/12) 100 (15/15) 55 (6/11) 43 (6/14) 31 (14/45) 61 (37/61)
hyd*1 1 (1/9) 75 (9/12) 93 (14/15) 73 (8/11) 7 (1/14) 38 (17/45) 54 (33/61)
esp 33 (3/9) 92 (11/12) 27 (4/15) 73 (8/11) 93 (13/14) 40 (18/45) 64 (39/61)
psaA*3 3 (3/9) 75 (9/12) 93 (14/15) 82 (9/11) 64 (9/14) 42 (19/45) 72 (44/61)
cbh 44 (4/9) 100 (12/12) 80 (12/15) 100 (11/11) 93 (13/14) 56 (25/45) 85 (52/61)
fsr 67 (6/9) 100 (12/12) 100 (15/15) 0 (0/11) 100 (14/14) 67 (30/45) 77 (47/61)
gelE 100 (9/9) 100 (12/12) 100 (15/15) 100 (11/11) 100 (14/14) 96 (43/45) 100 (61/61)
Groups are comprised of abundant clonal isolates (n.3) and their single and double locus variants as determined by MLST analysis (Fig 3) and eBURST [24]:
CC21=ST21&70, CC9=ST9&106, CC2=ST2&6, CC8=ST8, 64, 90, &112, and CC40=ST 40&114. Numbers in bold indicate percentage of isolates positive for the specified
genotype for a given grouping as calculated from the number of positive versus total isolates in parentheses. Genes investigated above the dashed line encode
antibiotic resistance determinants, while those below the dash are known to the pathogenicity island of E. faecalis and/or code for auxiliary enzymes (see Table 2).
Antibiotic resistance genotypes encoded by genes other than those listed are not included in this table. *=putative nuclease and glycosyl hydrolase genes
doi:10.1371/journal.pone.0000582.t003
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Figure 4. Virulence-associated phenotypes and corresponding genotype for all isolates.. Phenotypes were determined by microdilution assay for
antibiotic resistance or enzyme-specific tests for auxiliary enzymatic traits. Genotypes were determined by PCR amplification and/or hybridization for
genes known to encode each phenotype. A positive genotype is indicated by the presence of one or more genes known to produce a given
phenotype (e.g. genotypically positive vancomycin strains may contain the vanA or vanB genes—a strain containing both would only be counted
once).
doi:10.1371/journal.pone.0000582.g004
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+). For gelatinase, the lack of phenotype in the presence of
a positive genotype in many cases has been attributed to the
absence of a known gelE regulator fsrB [68]. In the present study,
27 of the 46 gelE positive isolates that did not display a gelatinase
positive phenotype were fsrB negative by PCR, while all gelatinase
positive isolates tested positive for fsrB (Table S2). All three
auxiliary trait activities assayed were present in the major MLST
groups and branches of the cladogram lineages, with the exception
of gelatinase activity, which was not present in any isolate of CC8.
Upon further examination, it was found that all of the isolates of
CC8 tested positive for the gelatinase gene, gelE, but negative for
the fsrB regulator of gelatinase expression [68].
Comparative genomic hybridization analysis of
diverse E. faecalis isolates, and classification of core
genetic elements
Based on the MLST relatedness profiles of strains tested, we
examined eight strains that spanned the diversity of the species by
comparative genomic hybridization. The goal was to identify genes
common to maximally diverse strains of E. faecalis, thereby defining
the core genome. It was further of interest to assess the penetration of
variable traits occurring in the V583 genome within diverse lineages
of the species. Six of these strains (ARO1/DG, Com6, Fly1,
HIP11704, D6, and JH1) represent diverse nodes of the MLST-
based cladogram (Fig. 2), unrelated to the known sequence strain,
V583. Strain MMH594 was included as an additional positive
control to verify detection of genes of the 17 kb portion of
pathogenicity island known to be deleted in strain V583 [19]. The
results of microarray genome hybridization analysis of the six strains,
and V583 and MMH594 controls, demonstrate the relatedness
between diverse strains of E. faecalis and V583 with respect to its
variable gene content (Fig. 5). Probe sets for the array are ordered
according to the V583 genome sequence, while additional plasmid
and antibiotic resistances genes are arranged independently.
Comparison of divergent E. faecalis genomes to strain V583,
revealed some V583 genes that were present among all strains
tested, and others that were variably present. Variable regions
were found to correspond to integrated phages, plasmids, and
transposable elements previously identified in silico in the V583
genome [19], as well as an additional 60 ORF phage-related
variable region not previously identified (region 9). Region 9,
present only in V583 and MMH594, is flanked by site-specific
recombinases and contains putative metabolic and hypothetical
genes, and may represent a new pathogenicity or fitness island. In
strain V583, the vanB segment (region 10) is flanked by ORFs with
high sequence similarity by BLASTp analysis (http://www.ncbi.
nlm.nih.gov/blast) to those occuring in mobile elements. Because
MMH594 isolation predated that of V583, suggesting that vanB
was the more recent acquisition, the vancomycin resistance
element appears to have inserted into the 60 ORF region 9,
which seems to have entered the species in this lineage (ST6).
Region 6, a region of the V583 genome previously identified to be
atypical in GC composition [19], appears to be extended 8
additional ORFs (EF_1847-EF_1897 instead of EF_1855-
EF_1874) based on both the presence of these ORFs in strains
identified by comparative genomic analysis, and the presence of
a flanking site-specific recombinase. (see microarray data files at
http://www.ebi.ac.uk/arrayexpress, accession number E-MEXP-
1090). This region is present in the closely related strains V583
and MMH594, and in a divergent strain, D6.
Relatedness based on similarity in gene content was calculated
based on the percentage of non-divergent (Present) probe sets in
each strain and Pearson correlation coefficients (see supporting
microarray information and materials and methods). To the extent
that gene content reflects fitness for a particular habitat, this
comparison provides a independent approach from MLST for
investigating the ecological relationship of E. faecalis isolates. As
shown in the dendrodram at the top of Figure 5, MMH594 and
V583 (both ST6) group together as would be anticipated based on
known relatedness in gene content, which includes the pathoge-
nicity island, capsule gene and MLST genes. However, relatedness
based on variable gene content did not parallel MLST (Fig. 2),
indicating that as expected for mobile elements, variable traits
penetrate the species independently of genome sequence drift.
Each strain exhibited a minimum identity of 72% with the V583
chromosomal probe sets, and a minimum of 67% of the total E.
faecalis probe sets (which includes E. faecalis genes not found in
V583; Table 4). As expected, most of the differences in gene
content between the strains tested and V583 appear to stem from
variations in putative mobile element content, which is not
measurable by MLST. Since only the genome sequence of strain
V583 is known, there undoubtedly are many undiscovered
variable traits in the non-V583 lineages tested, that if examined
could lead to the identification of additional relationships among
these strains.
The core E. faecalis genome, as defined by the number of genes
present in all 8 strains based on the ORFs included in the
microarray, consists of 2057 of the 3091 ORFs (2129 of the 3582
total probe sets, which includes redundancies; Fig. 6). Core and
variable genes were categorized by orthologous group, according
to NCBI COG designation (Clusters of Orthologous Groups,
http://www.ncbi.nlm.nih.gov/COG). Core and accessory genes
were further analyzed and ranked by the number of strains for
which a present call was made for each probe set, and for
predicted cellular role (Fig. 6). All of the core genome ORFs are
located on the V583 chromosome; none were associated with
extrachromosomal plasmids.
Of probe sets not part of the core genome but common in the
majority (five or more) of the eight strains examined, 370 were
identified. Of these, 236 probe sets represented poorly character-
ized or unassigned gene functions, and the remaining 134 spanned
all of the general COG categories. Of the seven identified phage
regions of the V583 genome, only one is represented in the core
genome: PHAGE02 [19]. In addition, the majority (9 of 11) of
predicted V583 phosphotransferase systems (PTS) [19] for the
transport of sugars are present in the core genome, including those
for cellobiose, fructose, glucitol, glucose, maltose, mannitol,
mannose, sucrose, and trehalose. Only the galactitol and N-Acetyl
galactosamine PTS systems from V583 were not present in all
eight isolates. Examination of the core genome for identified two-
component signal transduction systems from V583 [69] showed
that 12 out of 17 of these systems, as well as an orphaned response
regulator, are present in all strains tested. These include HK/
RR01, HK/RR02, HK/RR03, HK/RR04, HK/RR05, HK/
RR06, HK/RR07, HK/RR09, HK/RR10, HK/RR13, HK/
RR14, HK/RR17, and RR18. Furthermore, we found high
conservation of genes identified as having a potential role in stress
responses [19] within the core genome. Of the 56 stress-response
related ORFs in V583, which represent oxidative, osmotic, and
metal-ion resistance mechanisms [19], 54 are present in the core
genome of E. faecalis.
Strain relatedness and presence of pathogenicity
island
A pathogenicity island (PAI) was found to occur in E. faecalis strain
MMH594, with derivatives in strains V583 and V586 [10]. This
Diversity of E. faecalis
PLoS ONE | www.plosone.org 12 July 2007 | Issue 7 | e582Figure 5. Visualization of final absent and present calls for all probe sets across 8 distinct E. faecalis isolates. Comparative genomic hybridization
was performed on DNA from isolates V583, MMH594, JH1, HIP11704, D6, ARO1/DG, Com6, and Fly1 as described in materials and methods. Probe sets
are ordered according to the E. faecalis V583 gene sequence and the Affymetrix library file. Absent probe sets are in white; present probe sets are in
black. Clustering of the strains was based on complete linkage using the Pearson correlation coefficient for the Absent/Present calls (A=0, P=1). The
same clustering pattern is generated when average signal intensity values are used instead of Absent/Present calls (not shown). The numbered
regions on the left correspond to the following previously identified and unidentified mobile genetic regions from strain V583: 1) EF_0125-EF_0166,
2) EF_0302-EF_0355 (PHAGE01), 3) EF_0479-EF_0628 (V583 PAI), 4) EF_1275-EF_1293 (PHAGE02), 5) EF_1416-EF_1489 (PHAGE03), 6) EF_1847-
EF_1897, 7) EF_1987-EF_2043 (PHAGE04), 8) EF_2084-EF_2145 (PHAGE05), 9) EF_2240-2282/EF_2335-2351, 10) EF_2284-EF_2334 (Tn/vanB), 11)
EF_2512-EF_2545, 12) EF_2798-EF_2856 (PHAGE06), and 13) EF_2936-EF_2955 (PHAGE07) (see text).
doi:10.1371/journal.pone.0000582.g005
Table 4. Present calls for Comparative Genomic Hybridization probe sets by isolate.
..................................................................................................................................................
Strain ARO1/DG Com6 Fly1 JH1 HIP11704 D6 MMH594 V583
Present calls for V583 chromosome 2417 2422 2535 2404 2615 2483 3110 3256
% present calls for V583 chromosome 73.09 73.24 76.66 72.69 79.07 75.08 94.04 98.46
Present calls in all bacterial probe sets 2493 2425 2566 2407 2739 2559 3210 3409
% present calls in all bacterial probe sets 69.60 67.70 71.64 67.20 76.47 71.44 89.61 95.17
doi:10.1371/journal.pone.0000582.t004
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PLoS ONE | www.plosone.org 13 July 2007 | Issue 7 | e582region encodes known and putative virulence determinants,
surface adhesion factors, carbohydrate metabolism pathways, the
cytolysin operon, a putative bile salt hydrolase, as well as many
other genes of unknown function and homologs to virulence
factors in other bacteria [10]. Many genes in this island, such as
the cytolysin operon, have been identified on plasmids, transpo-
sons, or other mobile elements, and appear to have integrated into
the chromosome at various points in its evolution. In order to
survey which regions of the known PAI were present in the strains
of our collection, we selected six functionally unrelated genes
located across the pathogenicity island to serve as sampling points
(Fig. S1). The pathogenicity island (PAI) associated genes we
surveyed were present in many nodes of the dendrogram, and in
strains from many different sources and dates of isolation.
Through PCR and dot blotting for the six PAI genes from Fig.
S1, we found that CC9, CC2, and CC8, possessed more of the
PAI regions (and also antibiotic resistances) tested than did other
clonal clusters (Fig. 3 and Table 3). Bile salt hydrolase, cytolysin,
and gelatinase genes, as well as five of six PAI genes sampled (the
exception being the gls24-like gene) can be found in strains isolated
before 1951, including in some of the oldest strains in our
collection. The exception, gene EF0117 which specifies a gls24-like
gene, is located near one end of the PAI and did not appear in
strains of our collection until the 1980s in isolates from ST6, of
which the majority test positive. The gls24-like gene has high
homology to the gls24 gene (EF0080), which has been linked to
stress responses in E. faecalis [70]. This gls24-like gene appears to
have penetrated other lineages (STs 11, 28, 36, and 64) in the early
1990’s. We found gls24-like in isolates of different regions of the
dendrogram (Fig. 3), however, it was the rarest of the PAI genes
assayed and did not appear in any CC21 or CC40 isolates
surveyed.
The nuclease homolog, nuc1, (EF0031) exhibits sequence
similarity to staphylococcal nucleases that hydrolyze DNA and
RNA [71] and is located near the opposite end of the PAI from the
gls24-like gene (EF0117). nuc1 was absent in strains of our
Figure 6. Classification of core and dispensable sequences in 8 strains of Enterococcus faecalis. Data from comparative genomic hybridization
analysis of isolates V583, MMH594, JH1, HIP11704, D6, ARO1/DG, Com6, and Fly1 are organized by the number of strains for which each probe set is
detected (top to bottom). Absent probe sets are in white; present probe sets are in black. Clustering of the strains was based on complete linkage
using the Pearson correlation coefficient for the Absent/Present calls (A=0, P=1). Genetic elements were classified as part of the core genome if
present in all strains tested. COG designations were obtained from the National Center for Biotechnology Information (NCBI). Some genes/probe sets
represent more than one COG category.
doi:10.1371/journal.pone.0000582.g006
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PLoS ONE | www.plosone.org 14 July 2007 | Issue 7 | e582collection isolated prior to 1950. It was present in every CC2 isolate
and was absent from all CC21 isolates, however a pattern of nuc1
penetration the species is not evident. The other sampled PAI genes,
cylB, esp, the hydrolase (EF0077), psaA, and cbh, were found in isolates
of our collection dating as far back as 1926; the pattern by which
these genes entered the species could not be deduced from this set.
Given that the cytolysin operon is known to be on conjugative
plasmids in several of the strains in our collection [11,43,72–74],
we investigated whether the cytolysin determinant of other strains
was highly transmissible, as is known for the cytolysin encoding
plasmid, pAD1 [75], or on less mobile PAI [10] or other element
[31]. Mating experiments showed that 51% (18/35) of the
cytolytic strains were able to transmit cytolysin in a mixed colony
at a high rate. When aligned to the position of isolates on the
dendrogram (Fig. 2), the transmissibility of cytolysin corresponded
to specific regions and groups. For instance, all of the cytolysin
positive strains in CC21 and CC40 were able to transfer cytolysin
in a mixed colony, presumably by conjugation as known for the
prototype plasmid pAD1 encoded determinant [75]. Except for
strain MMH594, isolates in CC2 that were positive for cylB were
phenotypically not cytolytic, precluding detection of transconju-
gants. Transfer of the known PAI-conferred cytolysin determinant
within MMH594 was not observed in the mixed colony, consistent
with previous observations [32]. Within CC2, V583 and V587
which were isolated from separate patients, are known to carry
vestiges of the cytolysin operon within their pathogenicity islands
[18]. Part of this operon was deleted in strain V583 and
a transposon insertion rendered the V587 cytolysin inactive
([10], V587 data not shown).
Among the eight isolates used for comparative genomic analysis
by microarray, no pathogenicity island genes were common to all
of the strains, supporting the proposition that it is not part of the
core E. faecalis genome. Data obtained independently by sampling
for the presence of genes within the PAI, for antibiotic resistance,
and for other genes detailed in this study were generally supported
by the results of the microarray analysis. The sole exception was
detection of a previously unknown polymorphism observed in the
cps locus of strain Fly1, which had no cpsD by microarray, but
otherwise fit CPS type 5. With respect to genes of the
pathogenicity island, the microarray data for the 8 strains tested
was consistent with the results of sampling the six PAI loci shown
in Fig. S1 (Table 5), validating this set of genes as a useful tool for
rapidly probing strains for the presence of various regions of the
PAI. Based on the presence of the six representative PAI genes
sampled in our collection, we estimate that the middle regions of
the PAI between EF0056 (esp) and EF0095 (psaA) were introduced
into E. faecalis by the early 1900s, if not before. Comparative
hybridization analysis also indicates that the PAI has integrated
into multiple MLST lineages, as previously suggested by
Nallapareddy et al. [22], and is present in strains isolated from
both animals and humans (Table 5).
DISCUSSION
This investigation was undertaken to provide new insights and
a global view of the diversity of the species E. faecalis. We observed
differences between phylogenetically separate groups for pathoge-
nicity island content, antibiotic resistance determinants, and
capsule operon polymorphisms, which we hypothesize are due to
niche preferences within the species. Variable genetic traits confer
niche specialization and virulence to bacteria, including E. faecalis.
To characterize the diversity of the species, to determine what
constitutes the core species characteristics, and to determine the
extent of penetration of various traits into the species, we
characterized a diverse collection of E. faecalis isolates by MLST,
comparative genomic hybridization, and directly assessed select
genotypic and phenotypic properties. As a starting point, we
capitalized on the efforts of previous investigators who, over the
past six decades, developed collections of serologically unique E.
faecalis strains [25,39,76]. We complemented these collections with
additional isolates from over the past century, and from a variety
of geographic locations. Of the 51 different sequence types we
identified, the majority (29 sequence types, 57%) had not been
detected in previous studies [24,77].
Our studies show that the previous collections of serologically
unique strains were not only antigenically diverse, but remarkably
genetically diverse as well. This was somewhat surprising in that
expression of a new surface protein, potentially encoded by
a mobile element such as a phage or transposon, could generate
a novel serotype. Only one example was identified where
serological type strains from the Maekawa collection [25] were
of the same MLST sequence type–namely T1 and T13, both of
which were MLST sequence type 21. The remaining 19 strains of
the Maekawa collection constituted 19 sequence types covering
most of the unrooted dendrogram that represents the species
(Fig 2). The five most common serotypes identified by Maekawa et
al. [25,40] in epidemiologic studies, do not appear closely related
genetically (serotypes T1, T2, T4, T7, and T9; Figs. 1 and 2; [40]).
This suggests that either discrete ecologies select for the presence
of these 5 lineages, or that the host mounts a transient immune
response promoting a temporal rotation among these lineages.
Additional isolates in the collection resolved into 31 additional
STs, for a total of 51 STs. Of these 51 STs, 38 were represented
only once in our collection. Of the Maekawa serotypes that were
reported to be most often isolated in studies of strains from the
U.K., U.S.A., and Japan [40], only T1 and T7 were members of
MLST clonal clusters deriving from this collection (CC21 and
CC8, respectively).
Capsules are typically highly variable traits of pathogens, such
as Streptococcus pneumoniae, and this variation is driven by evasion of
host immune response [78–80]. The cps capsule locus of E. faecalis
was discovered in part with the use of Maekawa serotyping
antiserum (serotype 2/strain T2), and consists of the 11 open
reading frames cpsA through cpsK [34,44,45]. The first vancomy-
Table 5. Presence of 6 representative PAI genes compared to total PAI probe sets by comparative genomic hybridization.
..................................................................................................................................................
Strain Com6 Fly1 ARO1/DG JH1 V583 HIP11704 D6 MMH594
Origin commensal insect dog clinical clinical clinical pig clinical
Sequence type (ST) 21 101 108 40 6 4 16 6
6 gene PAI profile
A 0/6 0/6 0/6 2/6 4/6 5/6 6/6 6/6
CGH PAI probe sets
B 0/141 0/141 3/141 56/141 125/141 111/141 138/141 137/141
A6 gene PAI profile includes the nuclease homolog, cylB, esp, xylS homolog, psaA homolog, and gls-24 like genes outlined in Fig S1 and Table 2.
BPAI probe sets were designed to the combined V583 and MMH594 PAI sequences (EF_0479-EF_0628 and EF0001-EF0129, respectively) and represent 139 ORFs.
doi:10.1371/journal.pone.0000582.t005
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PLoS ONE | www.plosone.org 15 July 2007 | Issue 7 | e582cin-resistant isolate, V583, the first characterized pathogenicity
island-containing strain MMH594, and a clinical isolate adapted
for use in the laboratory FA2-2, were all shown to react with type 2
antiserum, a phenotype that is dependent on the presence of the
capsule operon including, in particular, cpsF [34,45].
In studies of streptococci, where capsule variation alters
serotype, an MLST type was found to correspond to one or more
particular serotypes and a given serotype might be common to
many clonal complexes or sequence types [81,82]. Of the 51
sequence types identified, 25/51 were found to be CPS type 1, 14/
51 of CPS type 5, and 12/51 of CPS type 2. The vast majority of
CPS type 1 lineages harbored 3 or fewer virulence traits (18/25;
72%), or 2 or fewer antibiotic resistances (19/25; 76%) (Fig. 7).
Similar proportions were observed for CPS type 5 strains (79%
[11/14] possess 3 or fewer virulence traits; 79% [11/14] possess 2
or fewer antibiotic resistance traits). However, half or more CPS
type 2 strains (58% [7/12]) harbored 4 or more virulence traits, or
3 or more (58% [7/12]) antibiotic resistance traits (Fig. 7). This
observation suggests that CPS2 strains tend to colonize sites where
antibiotic resistance genes and virulence traits are advantageous.
As the capsule locus, the pathogenicity island, and antibiotic
resistances are known not to be physically linked in strain V583
(the only strain for which a genome sequence exists), this
observation supports the hypothesis that independent selection
has driven the convergence of virulence traits, antibiotic
resistances and the type 2 capsule.
Expression of the type 2 capsule has been associated with
decreased opsonophagocytosis [44]. That ST6 isolates, which are
uniformly of this capsule type and clinical in origin, had the
greatest variety of both antibiotic resistances and PAI genes tested,
makes the nexus of these traits of special interest in the evolution of
highly virulent clones of the species (Fig. 3 and Fig. 7) Throughout
our collection, the three known cps operon polymorphisms [34,83]
(CPS) were consistent within individual STs, although within an
ST variation in antibiotic resistance and virulence traits occurred.
This suggests that although the capsule locus polymorphism is
a variable trait within the species, it varies at a lower rate than
other traits known to reside on mobile elements [84]. Alterna-
tively, it suggests that a change in capsule type may give rise to
a new lineage, perhaps by enabling that strain to outcompete the
parental type to which the host has responded. That all three CPS
variations were found in all of the major branches of the
dendrogram supports the hypothesis that there is horizontal
transfer. However, a lack of obvious transfer or transposition
functions associated with the capsule operon leaves as an open
question the mechanism.
The present study revealed variation in the penetration of
antibiotic resistances and genes of the pathogenicity island
between major clonal clusters, as well as non-clustering isolates.
The tetracycline class of antibiotics were discovered in 1945, and
put into regular therapeutic use by 1950 [85,86]. Within 2–
3 years, tetracycline resistant strains of enterococci were isolated
[86]. The oldest isolate with tetracycline resistance in our
collection dated back to 1954. Tetracycline resistance was the
only antibiotic resistance trait that occurred among isolates of
known commensal origin included in this study. Its occurrence
among such strains was known from previous studies of gut flora
populations [46]. Tetracycline resistance in enterococci can be the
result of genes encoding ribosomal protection mechanisms (TetM-
like) or efflux pumps that actively transport antibiotic out of the
cell (TetL-like), both of which were found in our strains [87].
Tetracycline and its derivatives are broad-spectrum antibiotics
that have been commonly used for the past 67 years to treat
bacterial infections, thus their regular use and spectrum of activity
has exerted substantial pressure for E. faecalis strains to harbor
resistance determinants. As such, tetracycline resistance is the most
common resistance found in our collection (62/106 isolates) and
has penetrated 25 of the 51 sequence types we identified.
Vancomycin, a glycopeptide antibiotic, was discovered in 1952
and was quickly brought to market to combat infections due
penicillin resistant bacteria [88]. However, vancomycin use has
been limited since its introduction due to problems with toxicity,
administration, and the availability of other antibiotics [88].
Resistance of group D streptococci (enterococci) to vancomycin
was documented in isolates in 1968 [86], though it is unclear in
which specific species this resistance occurred. The use of
vancomycin increased during the 1980s, which likely contributed
to the rise in resistant organisms that soon followed [88].
Vancomycin resistance in enterococci was encountered in France
and the U.K. in 1986, as a result of the vanA gene cluster found in
enterococcal isolates [89–91]. Vancomycin resistance mediated by
vanA or vanB genes was found in only 15/106 strains in our
collection. A review of our vanA-containing isolates indicates that
this genotype first appeared in E. faecalis strains in ST6 (CC2) and
ST28 (1990s) and was later acquired in ST108, ST104, and ST4.
Vancomycin resistance due to the vanB genes was found in 1987 in
Figure 7. Antibiotic determinants and pathogenicity island composition per sequence type lineage, aligned by capsule locus (cps) variation
(CPS type). The percentage of sequence type lineages positive for each antibiotic resistance and pathogenicity island listed in Fig 3 were alligned by
CPS capsule type and arranged in descending order. Capsule types are invariant for strains within individual sequence type lineages. Details of
capsule operon (cps) arrangements are outlined in Materials and Methods.
doi:10.1371/journal.pone.0000582.g007
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PLoS ONE | www.plosone.org 16 July 2007 | Issue 7 | e582the E. faecalis strain V583 [18], which is in ST6 (CC2). vanB next
appears in ST64 (CC8) in 1991, followed by ST2 and ST103 in
2002. Our study identified vancomycin resistant strains in eight
distinct STs, six of which had not been previously identified as
harboring van genes [24]. The diversity of sequence types
harboring van genes in our set illustrates an extensive spread of
this resistance among E. faecalis lineages in less than twenty years
since resistance was first discovered.
Ampicillin is a b-lactam antibiotic, the first and most famous of
which is penicillin [92]. Discovered in 1928, b-lactams came into
widespread use in 1942 as the first class of antibiotics used to treat
bacterial infections [93]. In the initial characterization of the
bacteriocidal action of penicillin it was clear that the enterococci,
including E. faecalis, were resistant to the antibiotic [92]. The
enterococci have an intrinsic resistance to b-lactam antibiotics that
is likely due to a low affinity of the penicillin-binding proteins for
the antibiotic [94]. It was not until 1981 that high-level resistance
to b-lactams due to penicillinase production was identified in E.
faecalis in strain HH22 (CC2) [95]. Ampicillin resistance was the
least encountered antibiotic resistance in our collection (10/106).
The spread of ampicillin resistance conferred by b-lactamase
appears to be restricted to two of the most common clonal groups
in our set: CC2 and CC8. Penicillin and its derivatives have been
heavily used since their inception, thus the lag time between the
introduction of b-lactam antibiotics and the discovery of b-
lactamase enzymes in E. faecalis cannot be attributed to low use.
That there is likely little selective advantage for acquiring and
maintaining penicillinase enzymes in a intrinsically resistant
organism is the most likely reason b-lactamase has not penetrated
the species more extensively. Interestingly, the first b-lactamase
and vancomycin resistance determinants identified in E. faecalis
were both independently identified in ST6 strains of CC2.
Chloramphenicol was introduced for therapeutic use in 1949,
however its use is currently restricted in the U.S. due to side effects
[86]. Resistance among group D enterococci to chloramphenicol
was noted immediately upon its inception [96]. In enterococci, this
resistance is most commonly associated with the chloramphenicol
acetyl-transferase gene, cat [57]. We evaluated our isolates for
chloramphenicol resistance and found that all 12 chloramphenicol
resistant strains were positive for chloramphenicol acetyl trans-
ferase. Tracing the introduction of this resistance through our
collection, we found that the first isolates with cat activity belong to
ST9 (CC9), and date back to 1961. Chloramphenicol resistance
was then absent from our strains until the mid-1980s, when it
occurred in ST9 (CC9) and ST6 (CC2). By 1991, resistance
moved to ST64 (CC8), then ST28 in the mid-1990s, and finally
ST40 (CC40) in 2002. It is intriguing that of the 12 chloram-
phenicol resistant isolates we found, only one did not belong to
a common clonal cluster (strain SF21521, ST28). Though
resistance to chloramphenicol was found in multiple lineages in
our collection, the restricted use of chloramphenicol as a thera-
peutic antibiotic has probably limited the number of resistant
organisms in the population by decreasing the selective pressure
for maintaining the genetic determinant.
Gentamicin belongs to the aminoglycoside class of therapeutic
antibiotics, the first of which (streptomycin) was introduced in
1943 [97]. Enterococci are intrinsically resistant to low levels of
aminoglycosides (#250 mg/ml), while high-level aminoglycoside
resistance ($250–2000 mg/ml) is the result of acquired resistance
[98,99]. High-level acquired resistance can be caused by three
different types of aminoglycoside modifying enzymes: phospho-
transferases (APHs), acetyltransferases (AACs), or nucleotidyl-
transferases (ANTs) [100]. The most common source of
aminoglycoside resistance in E. faecalis involves the bifunctional
enzyme aac69-aph20 [50]. We found gentamicin resistance by the
aac69-aph20 enzyme most frequently (33/35 gentamicin resistant
isolates). Two isolates did not test postitive for the bifunctional
enzyme: strain JH1 (ST 40), for which the 3950 APH gene was
previously characterized [56], and strain YI6-1, for which the
mechanism was not identified. Aminoglycoside resistance via
aac69-aph20 first appeared in our collection in strain HH22 (ST6,
CC2) in 1981, which was also the first identified b-lactamase-
producing E. faecalis [95]. Aminoglycoside resistance was pre-
viously identified in HH22, in the first publication describing high-
level gentamicin resistance in the U.S. [101]. Gentamicin
resistance transferred by conjugation categorically with b-lactam
resistance from HH22 [95,101], signifying that resistance to both
antibiotics was acquired simultaneously in this strain. In fact, all b-
lactamase positive isolates in our collection are also resistant to
high-levels of gentamicin, though a genetic link between these
determinants was not investigated. The next occurrence of aac69-
aph20 in our set was in ST9 and ST106 (both CC9) in the mid-
1980s, followed by ST64 (CC8) in 1986, ST11 (distant relative of
CC9) and ST109 (CC2) in the early 1990s. The bifunctional gene
was next found in ST28, a single locus variant of ST11, in the mid-
1990s. By 2001/2002 the aac69-aph20 had expanded to ST2 (CC2),
ST4, ST103, and ST104; the gene also spread to ST16, however
the date of this transfer is not known. The pervasive spread of this
determinant among different lineages in the species hints that
persistent use of aminoglycosides in the last several decades has
permitted the expansion of this determinant between enterococcal
isolates.
Erythromycin, a macrolide antibiotic, came into use in 1952.
Within a year, resistant isolates of group D streptococci
(enterococci) were identified [86]. Many genes have been found
to contribute to macrolide resistance in enterococci, however
resistance to erythromycin in E. faecalis is typically mediated by the
ermB rRNA methylase gene [102]. Within our collection, all 40
erythromycin resistant isolates contained the ermB gene. The first
occurrence of ermB in our group was in ST40 (CC40) and ST55
from the mid 1970s. By the mid 1980s, ermB had spread to ST6
(CC2), ST9 (CC9), and ST64 (CC8). By the early 1990s, ermB
could be found in five additional sequence types, and by 2002 ermB
had been transferred to an additional seven sequence types. In
total, 17/51 sequence type lineages were found to contain the ermB
gene for macrolide resistance. In addition, all vancomycin resistant
strains in our study (either vanA or vanB mediated) harbored the
ermB gene. The vanA gene was previously shown to be located on
the same plasmid as ermB [103], though we could find no prior
work describing linkage of vanB and ermB. Antibiotic resistance
genes are commonly clustered together on mobile plasmids and
phages, leading to the co-selection of resistance determinants with
the use of a single class of antibiotic. Moreover, antibiotic
treatment of E. faecalis infections often involves the use of multiple
antibiotics to achieve synergistic killing effects [104]; thus the
likelihood of a strain acquiring multiple antibiotic resistances at
once is great.
The occurrence of PAI genes and acquired antibiotic resistances
by clonal group reveals a pattern between the range of isolation
dates and the average number of these genes observed: generally,
the more PAI and antibiotic resistance genes found, the shorter the
range of isolation dates within the clonal clusters. The five most
common clonal clusters: CC21, CC9, CC2, CC8, and CC40,
represented 58% of the 106 isolates examined by MLST in this
study. CC2 isolates have the shortest range of isolation dates of any
clonal group (1981–2003, 22+ years) and the greatest number of
PAI and antibiotic resistance genes on average (7.5, 61.8), while
CC21 have the widest range of isolation (1930s–2006, 75+ years)
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61.2). CC9 strains have a range of 31+ years and 6.8 PAI/
antibiotic genes (61.5), CC8 have a range of 60 years and 5.8
(63.5), and CC40 span 54+ years with 3.6 of these genes on
average (61.4). The non-ST64 isolates of CC8 alter the age range
and genetic content of the group significantly, and if left out,
change the range to 13 years and the average to 7.3 (62.5). These
patterns point to sudden clonal expansion of groups with greater
virulence potential and mechanisms for resistance, and the
persistence of clusters over time with few PAI genes and antibiotic
resistances. Clusters with the most PAI genes sampled carried the
most acquired antibiotic resistance traits (Fig. 3), suggesting that
some lineages—particularly CC2—may be especially proficient at
DNA exchange. Since the PAI is not physically linked to antibiotic
resistance [10], this also indicates that there is independent
selection for both antibiotic resistance and increased virulence. As
has been observed in other species, the non-grouping/singleton
isolates of our collection often contained fewer PAI and antibiotic
resistance genes than isolates belonging to genetically similar
clusters [105–107].
The frequency of occurrence of genes sampled from the
pathogenicity island by lineage (51 STs) was: the psaA homolog
49% (25/51), esp, 47% (24/51), glycosyl hydrolase 41% (21/51),
cylB 39% (20/51), nuc1 37% (19/51), and gls24-like 20% (10/51).
15 sequence types (29%) had none of the tested PAI genes. The
majority of gls24-like positive isolates were found in CC2.
Differences in the frequency of various segments within the island,
even within a genetic lineage, suggests that there are modules
within the island that can vary independently of the whole, as was
proposed by other studies [10,32]. The nuclease homolog (nuc1)
was not found in any isolate from CC21 or in any strain isolated
prior to 1950. Some older strains (isolated #1950) were positive
for the accessory traits bile salt hydrolase, cytolysin, and gelatinase,
as well as the PAI-associated genes cylB, esp, hyd, and psaA. Two
PAI genes appear to have entered the species relatively recently:
nuc1, which appeared by 1951, and gls24-like (EF0117), which
appeared in isolates of our collection during the mid-1980s. This
gls24-like gene appeared in our collection in other sequence types
in the early 1990s in genetically distinct isolates: namely STs 11,
28, 36, and 64. These data suggest the gls24-like region of the
pathogenicity island is a more recent acquisition to the species,
however additional samples isolated prior to the 1980s would be
needed to identify the lineage and date in which this portion was
attained.
The PAI genes esp, hyd, psaA, and cbh, were found in isolates of
our collection dating as far back as 1926. Cytolysin and gelatinase
activity were present in an isolate dating from 1918 (SS-7)
however, both traits were described in the 1898 report of
enterococcal disease (then Micrococcus zymogenes) by McCallum
and Hastings [108], indicating both entered the species before the
20
th century.
Because we have identified the regions of the pathogenicity
island between the esp gene (EF0056) and the psaA homolog
(EF0095) in isolates dating back to 1926, we propose that most of
the elements of the known pathogenicity island have been present
in this species for a minimum of 80 years, as have the auxiliary
traits tested. Whether they occur as a single genetic element in
these strains remains to be determined. As most E. faecalis do not
cause infections, the high incidence of the auxiliary bile salt
hydrolase and gelatinase genes in the population suggests these
traits could have important roles in the commensal existence of
many E. faecalis lineages. Gelatinase in particular, has been shown
to affect the surface of the cell altering its behavior in biofilm
formation, and increases the lethality of infections [109–111].
However, its ubiquity within the population appears to be due to
a more central role in the commensal behavior of the species.
All strains isolated before the mid-1980s that were positive for
cytolysin easily transmitted this activity to a non-cytolytic recipient
strain by mating. Movement of the cytolysin operon to the
pathogenicity island, as typified in strain MMH594 [10], appears
to coincide with the emergence of the earliest ST6 lineage strains
in hospital wards. Interestingly, strain MMH594 is the only isolate
in CC2 of our collection that possesses an intact cytolysin operon
and is phenotypically cytolytic. Strains V583 and V587 are known
to have partial deletion of the cytolysin operon and IS element
insertions, respectively [10]. It is possible that the other cylB+
strains in CC2 carry cytolysin genes chromosomally and that these
operons have been made inactive as V583 and V587 have,
however we did not test this further. The selection forces for this
variation, either in vitro or in vivo, remain unknown, but may
represent the cyclic generation of unusually virulent lineages, their
establishment within a niche, and then their gradual attenuation.
Interestingly, integration of the cytolysin operon into the PAI
coincided in time with the appearance of the gls24-like gene
(EF0117) in the pathogenicity island. The appearance of both
regions occurred in ST6 (CC2), providing further evidence that
this lineage may be particular adept at acquiring exogenous genes
through recombination. Support for this proposition is found in
the observation that of the 14 variable trait genes specifically
analyzed in all strains in this study (nuc1, cylB, esp, hyd, psaA, gls24,
blaZ, cat, vanA, vanB, ermB, aac69aph20, tetL, and tetM), all of these
genes occurred at the greatest rate in lineages harboring the CPS 2
capsule locus polymorphism (which includes ST6) (Fig 7). All of
this data supports a model where entry of new traits into the
species mainly occurs first through a CPS 2 strain (where they are
found with the greatest frequency), then radiates outward through
horizontal exchange. Alternatively, entry and exit of mobile
elements through the species could occur randomly, with strains of
the CPS 2 polymorphism simply having a greater tendency to fix
these traits through recombination; and/or strains of the CPS 2
capsule polymorphism occur in sites where virulence traits and
antibiotic resistances are of greater selective advantage, i.e.,
infected sites, and hence become fixed in these lineages.
We selected strains representing the 7 deepest nodes spanning
the species dendrogram to identify those traits that are common to
strains representing the maximum diversity within the E. faecalis
species. This approach also allowed us to assess the extent to which
all other known variable traits had penetrated into the species. It
also allowed us to identify those genes that represent the core
genome for E. faecalis. To the extent that variable gene content
reflects niche selection, generation of a dendrogram of greatest
relatedness in gene content, as revealed by comparative hybrid-
ization, would be predicted to cluster strains according to those
that inhabit similar niches. This is in contrast to an MLST
relatedness dendrogram, which measures genetic distance of
strains. Clustering of isolates based on gene content by
comparative hybridization analysis is also useful for identifying
large scale insertions and deletions, which cannot be evaluated by
MLST analysis. Large regions of the V583 genome were noted to
be absent in other strains (represented as white in Fig. 5).
Previously identified elements of presumptive extra-enterococcal
origin make up the basis for most of these gaps. PHAGE02 (Fig. 5,
region 4 [19]) appears to have entered the species very early in its
history, is highly infectious, or includes an essential function, as all
eight isolates we evaluated were positive for this element. We
therefore operationally include the region previously identified as
PHAGE02 as part of the core genome of E. faecalis. To our
knowledge, this is the first phage associated with the core genome
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Lactococcus lactis bacteriophage Tuc2009 and the Streptococcus
thermophilus bacteriophage Sfi11, however, based on the V583
genomic sequence, PHAGE02 appears to be less than half the size
(15.3 kb) of either Tuc2009 or Sfi11 (39 and 39.8 kb, respectively)
[112,113]. The major structural genes of PHAGE02 do not
appear to have deteriorated to pseudogenes, as often happens
when loss of function of an element occurs, yet whether
PHAGE02 represents a functional phage or is merely a remnant
of a once-operative bacteriophage, is not clear. The advantage or
selective pressure that has allowed this region to persist is not
obvious and is the subject of ongoing work. In contrast, no
pathogenicity island ORFs are represented in all eight isolates
examined by comparative microarray hybridization. This would
be consistent with a more limited role for a pathogenicity island for
an organism that is mainly a commensal, or it may reflect a more
recent acquisition to the species.
Because E. faecalis is capable of colonizing a wide range of hosts
and environments, variants better suited for a particular niche
would proliferate and fill that niche, leading to well defined genetic
lineages of the species. Niche-specific phylogenetic lineages occur
in other species, such as the plant pathogen Pseudomonas syringae, for
which MLST analysis revealed clusters of isolates that were
confined to particular plant hosts [114]. A particularly virulent and
antibiotic resistant lineage of E. faecalis emerged in the mid 1980’s
that harbored an antiphagocytic capsule [44], a collection of
auxiliary virulence genes encoded on a pathogenicity island [10],
and multiple antibiotic resistances [19]. Interestingly, we found no
SLVs or DLVs of this lineage (CC2) that do not possess multiple
virulence traits and antibiotic resistances. The selective forces that
led to the convergence of these traits, the mechanisms involved
and the origins of this strain remain the subjects of ongoing study.
Additional strain references:
[115–156]
Additional table references:
[157–160]
SUPPORTING INFORMATION
Figure S1 Schematic of the pathogenicity island of E. faecalis
strain MMH594. Dashed marks designate the approximate site on
the island where gene products were assessed by PCR&Southern
hybridization for comparative analysis of PAI components in
reference strains. Each product is an amplification of the gene
listed directly above and is represented in Fig. 2 by the
corresponding letter designation.
Found at: doi:10.1371/journal.pone.0000582.s001 (0.05 MB TIF)
Table S1 Supplemental Table 1–Primers used in this study
Found at: doi:10.1371/journal.pone.0000582.s002 (0.04 MB
XLS)
Table S2 Supplemental Table 2–Strain data chart
Found at: doi:10.1371/journal.pone.0000582.s003 (0.19 MB
XLS)
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